1h Free Analyst Time
Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Amgen Inc (Amgen) is a biotechnology company, which discovers, develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases. It develops novel medicines in therapeutic areas of cardiovascular, oncology/hematology, inflammation, bone health, neurological disorders and nephrology. The company develops products using advanced human genetics to analyze the difficulties of disease and understand the fundamentals of human biology. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers through direct-to-consumer channels and through partnerships with other companies. The company has presence in Asia Pacific, Europe, Middle East, North America and Australia. Amgen is headquartered in Thousand Oaks, California, the US.Amgen Inc Key Recent Developments
- Mar 19, 2023: Amgen and NSG BioLabs announce Albatroz Therapeutics as winner of first Amgen Golden Ticket in Singapore
- Feb 22, 2023: Amgen announces cardiovascular study to evaluate association between lipoprotein(a) and cardiovascular risk in African Americans
- Jan 31, 2023: Amgen reports fourth quarter and full year 2022 financial results
- Jan 19, 2023: The Robert A. winn diversity in clinical trials award program established by the Bristol Myers Squibb foundation to expand with amgen’s commitment of $8 million
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- F. Hoffmann-La Roche Ltd
- Coherus BioSciences Inc
- Celgene Corp
- Eli Lilly and Co
- Millennium Pharmaceuticals Inc
- Novartis AG
- Clovis Oncology Inc
- Sanofi
- Janssen Pharmaceuticals Inc
- Regeneron Pharmaceuticals Inc
- GSK plc
- Teva Pharmaceutical Industries Ltd
- AbbVie Inc
- Repligen Corp
- Momenta Pharmaceuticals Inc
- Processa Pharmaceuticals Inc
- Janssen Pharmaceuticals Inc
- Teva Pharmaceutical Industries Ltd
- RenovoRx Inc
- AbbVie Inc
- Pfenex Inc
- Eli Lilly and Co
- Achillion Pharmaceuticals Inc
- F. Hoffmann-La Roche Ltd
- Coherus BioSciences Inc
- Millennium Pharmaceuticals Inc
- Clovis Oncology Inc
- Genentech USA Inc
- Celgene Corp
- Fresenius Medical Care AG & Co KGaA
- Curis Inc
- Takeda Pharmaceutical Co Ltd
- Sanofi
- Cassava Sciences Inc
- Mylan Institutional Inc
- Regeneron Pharmaceuticals Inc
- Ra Pharmaceuticals Inc
- GSK plc